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Artemisinin: From Chinese Herbal Medicine to
Modern Chemotherapy

Anthony Butler

Malaria is a disease that has blighted
humankind since early times. The first
antimalarial treatment available to Europeans
was the dried bark of the cinchona tree
from Peru. The main problem in its use was
adulteration by other material. The ‘active
principle’ was first extracted in 1820 and named
quinine. It was found to be a more powerful
and reliable drug than cinchona bark. Once
its chemical structure had been determined,
it was possible to synthesize substances
chemically related to quinine that were
equally powerful but could be manufactured
industrially. Mepacrine (atabrine) was amongst
the most successful, but had adverse side
effects. To avoid these side effects, further
chemical modification gave chloroquine, a
highly successful drug. This sequence is a
common way of converting an herbal remedy
into a modern-style chemical drug. It parallels,
to some extent, the process of potentiation
common in traditional herbal medicine. By the
1970s, drug resistance had developed

with chloroquine. To find and develop a new
antimalarial drug that worked on an entirely
different pharmacological principle, Chinese
scientists turned to their herbal compendia
(ben cao) and found that Artemisia annua (qing
hao) was frequently mentioned as a treatment
for intermittent fever. Whether, in view of the
distinctive doctrines of Chinese medicine,
it should be possible to extract an active
principle as described above is discussed. After
a very careful reading of the procedure given
for the use of qing hao, an active substance,
artemisinin, was extracted. Artemisinin has
a truly remarkable chemical structure, and
chemical modification produced artesunate,
the drug of choice. To prevent the development
of resistance, artesunate is used in combination
with other antimalarial drugs. Modern
pharmacology has largely ignored that other
substances in artemisia and the cinchona bark
may contribute to their therapeutic effect. This
matter is also discussed.
Keywords: malaria, quinine, chloroquine, artemisinin, drug discovery.
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Introduction
Malaria is a disease that has been with humankind since
the dawn of civilization. It has been suggested that more
humans have died of malaria than any other disease in
the history of the world (Packard 2007). Malaria is caused
by the presence of the parasite Plasmodium in the bloodstream. There are five species of Plasmodium that give rise
to malaria, of which P. falciparum is the most serious as it
can cause blood clots to form in the brain. This condition
is known as cerebral malaria and can be the cause of death.
One of the most characteristic symptoms of all types of
malaria is an intermittent fever, and the interval between
bouts corresponds to the reproductive cycle of the particular species of Plasmodium present in the patient’s blood.
The vector that carries the parasite from an infected
person to a new person is the female Anopheles mosquito,
as she requires human blood for the nourishment of her
eggs. Thus, any attempt to counter malaria in both the
individual and the community must include a drug with
directed toxicity towards Plasmodium and a means of
controlling the mosquito. Here we are concerned with only
the former. Malaria is a serious health problem in mosquito-inhabited parts of the world and is thought to cause the
death of around a million children a year in Africa since
their immune system is not fully developed (Maitland
2016). Those living permanently in malarious areas do
acquire some immunity as they mature.
Early Treatment for Malaria
Before the seventeenth century, Europeans tried a number
of herbal remedies, but none were effective. The first
success came with the Spanish colonization of South
America. Jesuit missionaries in Peru brought back to
Europe the bark of the fever tree (Cinchona spp.) (Rocco
2003). They likely learned of its healing properties from
Inca herbalists. It proved to be an effective remedy for
malaria; since the disease occurred all over central and
southern Europe, the effect of its arrival was dramatic and
meant that all who could afford the bark stood a chance of
recovering from malaria. It also allowed people to explore
and colonize malarious regions of Africa that previously
had been left alone. Demand for cinchona bark (sometimes
known as ‘Jesuits’ powder’) soon outstripped supply. One
reason for this was that removing the bark often killed the
cinchona tree, and the search for more bark took hunters
to more and more remote parts of Peru until, eventually,
the supply dried up. The British government managed to
obtain seeds of the cinchona tree around 1850, raised seedlings at Kew Botanic Gardens in London and established
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plantations in India. The trees did not flourish. The Dutch
authorities obtained some of the seeds and were much more
successful with plantations in Java, and this eventually
became the chief source of cinchona bark (Jercho 1993).
Extraction of Quinine
One of the main drawbacks with bark as a medicine is the
possibility of adulteration. Unscrupulous traders substituted bark from other trees, with no curative properties,
for cinchona bark. By the beginning of the nineteenth
century, organic chemistry had developed a number of
experimental procedures that allowed two French chemists to extract the active principle—that is, the substance
or substances amongst the dozens in the bark responsible
for cure of malaria—from the Peruvian bark (Pelletier and
Caventou 1820). The active principle in cinchona bark is
composed of two substances, which are both alkaloids:
quinine and cinchonine. The former is easier to isolate and
became the world’s first antimalarial drug. Thus quinine
(Figure 1) was born and rapidly became the drug of choice,
rather than the crude bark, for the treatment of malaria.
This is an early example of the transformation of an herbal
remedy into a modern-style chemical drug.
The curative properties of Peruvian bark were always
uncertain, even if the bark was authentic, because the
amount of quinine it contained varied according to the
season of harvesting. Extraction of the active principle
led not only to a more powerful but also a more reliable
drug as it was possible, by means of an assay, to assess
its purity. Quinine is still used today for the treatment of
malaria. The quinine story, of extraction and purification
from an herbal source, is a frequent sequence of events
in the development of a new drug from a medicinal herb.
The process may also be seen as parallel to that used in
biomedicine for the potentiation of an herbal remedy. A
further example is the use of powdered foxglove leaves
in the treatment of dropsy. They were the recommended
remedy for centuries, and it was not until the 1920s that
the glycoside responsible for its effect was extracted,
purified, and identified (Smith 1930). Digoxin is now used
in preference to the dried leaves.
Synthetic Antimalarial Drugs
The German effort during World War I was severely
compromised by poor access to quinine since fighting
took place in malarious parts of Europe, such as Italy and
the Balkans. During the 1920s, German chemists studied
compounds that retained some aspects of the chemical
structure of quinine but were much simpler and could be

Figure 1. Chemical structure of quinine
(A), mepacrine (B), and chloroquine (C).
(Butler, 2019)
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prepared in the laboratory and then in a chemical factory.
Many of them had quinine-like curative properties. A
particularly successful one was mepacrine, or atabrine
(Figure 1B). It was used extensively by United States (US)
troops during the war in the Pacific, and was found to be
superior to quinine as an antimalarial drug (Sneader 1996).
By 1945, the Americans had produced an even better,
chemically related, antimalarial drug: chloroquine (Surrey
and Hammer 1946; see Figure 1C). It was inexpensive to
make and showed few adverse side effects. For a number
of years, it was the drug of choice in the treatment of most
forms of malaria.
The sequence of events described above (synthesizing
compounds chemically related to the active principle as
extracted from the herb, thus leading to a more powerful
and effective drug) is a common part of modern drug
development. The lead comes not from the wisdom of
modern pharmacologists but rather from a humble herbal
cure. Chloroquine can be seen as the climax of a series
of chemical modifications of the quinine molecule, all
yielding a better drug than that supplied by nature.
Project 523
The triumph of chloroquine did not last for long. By the
late 1960s, its efficacy as an antimalarial drug showed a
significant decline; the malarial parasite had mutated
in some way as to resist the toxicity of chloroquine.
This is the parasite showing a characteristic of all living
things, namely the wish to live. Resistance caused grave
concern in the West and removed any chance of success
in attempts to eradicate malaria worldwide. It was also
causing concern in a part of the world of which, at that
time, we knew very little: China.
As China went through a period of great tumult and
cruelty during the Cultural Revolution (1966-1976),
Chinese soldiers were fighting a war in the jungles of
Vietnam against the South Vietnamese. It was a highly
malarious region and soldiers, normally free of malaria
because they took chloroquine as a prophylactic, started
to develop symptoms of the disease. Without effective

C
malarial chemotherapy, success in jungle warfare is almost
impossible. As a result, the Chinese government, led by
Mao Zedong at the prompting of Zhou Enlai, set up an
extensive research program (known as Project 523) to find
an alternative to chloroquine (Li 2007: 5-20). By 1967, over
five hundred scientists from sixty institutions had been
recruited, and the group included chemists, pharmacologists, entomologists, and doctors.
Although Mao’s aim was to modernize China, he insisted
that traditional Chinese medicine was a ‘great treasure
house,’ a phrase made famous by its inclusion in the ‘The
Little Red Book.’ He insisted that it should be taken seriously in spite of the views of some Chinese scientists that
it should be relegated to the waste bin. Accordingly, part
of the work of Project 523 was to see if there was anything
in traditional Chinese herbal medicine that would give a
lead to a new antimalarial drug in the way that Peruvian
bark had led to quinine. Herbs were harvested in the
traditional way and subjected to extraction and analysis.
The extract was then tested against murine malaria. To
see which herbs should be tested, it was necessary to know
how malaria was named in the old herbals. This matter has
been examined authoritatively by Hsu (2006a, 2009). The
term ‘intermittent fever’ (a hallmark symptom of malaria)
occurs in several texts and, although not all sufferers from
malaria display this symptom, it is so characteristic of the
disease that we may say that many people experiencing
intermittent fever had what we now call malaria. Any herb
said to treat intermittent fever was felt worthy of consideration, and this is what the scientists on Project 523 set
out to do (Hsu 2014).
The Doctrines of Chinese Medicine
We now come to a more complex problem peculiar to
the Chinese situation. In Chinese medicine, herbs were
prescribed according to a highly organized system, seeing
the functioning of the body in a holistic manner. Bad
health and disease were seen as the body working in a
non-harmonious way. Yin and yang were not in balance,
qi was not flowing freely, and the five elements (wu xing)
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were not in accord. An herb, or more likely a mixture of
herbs, would restore harmony and balance, but this might
work only in a human system and not in vitro or in a mouse
model. The malarial parasite is difficult to culture in vitro.
How closely was herbal prescribing in China inextricably
bound to its distinctive medical system? Modern western
phytotherapy has long since abandoned Galen’s theory
of the four humors, but the parallel process in Chinese
medicine has not occurred. A recent edition of the official Chinese pharmacopoeia (Chinese Pharmacopoeia
Commission 2015) uses the vocabulary of both Western
pharmacology and traditional Chinese medicine. To
believe that Chinese medicine is truly a ‘treasure house,’
do we have to accept what Sivin has called the ‘doctrines’
of Chinese medicine (Needham et al. 2000), or can we
ignore them and just note what herbs were used, as done
in Western herbalism?
Ackerknecht (1982) has argued that medical doctrines are
a reflection of the society in which they were conceived.
This is certainly true of Chinese medicine where, in the
early centuries of the first millennium, there were many
different medical doctrines. As the country became more
united, efforts were made by scholars over the centuries
to unify the doctrines. For example, The Yellow Emperor’s
Classic of Internal Medicine (Huang Di nei jing su wen) was
probably first written in the second century BCE and
revised by different scholars until Wang Bing completed
the work in the eighth century CE. To this day, it is still
consulted by practitioners of Chinese medicine, which
indicates the continuing importance of the doctrines. The
Emperor’s Classic describes in elaborate detail the workings
of yin/yang, the flow of qi, and balance of the wu xing.
Alongside medical theory existed the work of artisan
physicians, who prescribed cures for the ills that beset
humankind using mainly the herbs that grow so abundantly in China, but also the distinctive therapies of
acupuncture and moxibustion. Over the centuries, details
of therapeutic herbs were collected and published in
‘herbal compendia’ called ben cao. The earliest of the ben
cao, The Divine Husbandman’s Classic of Materia Medica (Shen
Nong ben cao jing) was completed in the first century BCE,
and many others were produced over subsequent centuries, reaching a climax in the posthumous publication of
the Ben cao gang mu (Materia Medica Arranged according to
Drug Description and Technical Aspects) by Li Shizhen in 1596
CE. It lists over 1,800 medicinal herbs. To what extent are
these remedies linked to the doctrines of Chinese medicine?
Needham, the great historian of all things scientific and
medical in medieval China, was in no doubt about the
link. He held that Chinese medicine was a body of knowledge derived directly from empirical findings. Chinese
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scholars may have been deficient in relevant information
because they lacked the tools for studying the human
body, but what they asserted may contain ‘heralds’ of
what modern science now understands about the human
body. He saw Chinese medicine as a river flowing into
an ocean that is ‘modern science.’ Other rivers include
Greek and Ayurvedic medicine, but modern science is
the unifying destination of them all. This view is fully
expounded throughout Needham’s writings, as well as
by Ho and Lisowski (1993). In opposition to this view,
Unschuld sees little connection between the doctrines
of Chinese medicine and the empirical prescribing to be
found in the ben cao. In his discussion of the Huang Di nei
jing su wen, he suggests that Section 74 is really the birth
of prescription pharmacy. This section is a substantial
one and the subject matter diverse (for a full discussion
of Unschuld’s commentary on the Huang Di nei jing su wen,
consult Unschuld 2003: 301-313). Interestingly, Section
74 points out that it is not only the qualities of each herb
in the remedy that makes the cure effective but also the
combination and the location of the disease. It suggests
there is a specific prescription for each diseased condition.
Significantly, he remarks that “neither the yin-yang nor
the five-agents doctrine are taken into account here”
(Unschuld 2003: 312).
According to Unschuld, the doctrines of Chinese medicine
were the speculations of scholars, detached and intellectually curious, and they changed in step with cultural
changes, but the cures were the province of artisans
interested in earning a living by offering hope to suffering
humankind. The cures remained remarkably constant. The
compilers of the ben cao may have been scholars but they
merely assembled material that had been unearthed by
others. Unschuld sums up the dilemma for those trying to
assess the value of Chinese medicine for the current time:
Are these foundations [the doctrines] required
to understand Chinese medicine and practice it
successfully, or can the substances and techniques
used in Chinese medicine be effectively separated
from their traditional background and explained
in terms of Western science without becoming
useless? (Unschuld 2003: 323)
His answer is an unequivocal yes, and one with which I
concur. When the separation is made, one of the barriers
to the use of the ben cao in drug discovery is removed
and the valuable observations contained therein may be
utilized in the modern treatment of disease by the process
of extraction and biological testing. In a limited but
valuable way, this has already been done. Ma huang, from
Ephedra sinica, is mentioned in the comprehensive

Figure 2. Artemisia annua.
(Butler, 2015)

Ben cao gang mu as treatment for impaired circulation and
coughing. Its medicinal properties were rediscovered
in the West by a Japanese chemist when ephedrine was
extracted from the plant and used, initially, as a mydriate
and later for the treatment of asthma and chronic pulmonary disease (Amatsu and Kubota 1913). An account of the
use of saltpeter (potassium nitrate, xiao shi) for the relief of
the pain of angina reveals a perceptive piece of empirical
prescribing that can be rationalized by recent discoveries
in cardiac physiology (Butler and Moffett 2009). In both
these cases, no reference is made to the doctrines of
Chinese medicine, but valuable insight has been gained
from information in a ben cao. What follows is an account
of an even more spectacular example.
Treatment of Malaria from the Ben Cao
Plants of the Artemisia genus are recommended in the
ben cao for the treatment of intermittent fever. The two
varieties mentioned are qing hao and huang hua hao. Hsu
has shown that, strictly, Artemisia annua (from which a
new antimalarial drug was eventually extracted in Project
523) is huang hua hao and not, as commonly supposed, qing
hao (A. apiacea) (Hsu 2006a). The researchers of Project 523
used A. annua (Figure 2), but called it qing hao (sweet wormwood). Initial experiments in extracting from the plant
some pharmacologically active material were unsuccessful
for an interesting reason. Instructions for the use of the
herb in the treatment of intermittent fever were given by
the fourth century alchemist and physician Ge Hong.
He writes:
Another recipe: qinghao, one bunch, take two sheng
[0.4 litres] of water for soaking, wring it out, take
the juice. Ingest it in its entirety. (Ge Hong, fourth
century: 3.16)
As part of Project 523, a modern version of this was tried
in which the leaves were immersed in hot water, the solid
material filtered off, and the filtrate tested on a malarial
murine model. No effect was observed. However, when a
nonpolar solvent (petroleum ether) was used instead of
hot water, material was extracted that proved to be highly

toxic towards the malaria parasite in a murine model. The
extract was named qing hao su (extract of qing hao) and
later given the Westernized name of artemisinin. Further
tests confirmed its effectiveness. It was purified and its
chemical structure determined. The reason why the traditional route of administration, as described by Ge Hong,
yielded a negative result was possibly the consequence of
the now standard process of filtering off any solid material
before testing the juice. Artemisinin forms in trichomes
of the plant (Xiao et al. 2016) and soaking will release it
into the water but it will not dissolve and therefore will be
present in suspension. Hsu (2006b) has pointed out that Ge
Hong instructs us to drink the juice without further refinement. Once in the body, it can be solubilized by formation
of a glucuronide—a frequently employed strategy in
human physiology—to give artemisinin human metabolite,
which is water-soluble, and this enters the bloodstream.
Artemisinin does not appear to be solubilized by any of
the other substances derived from the plant (Butler and
Renton 2000).
Chemical Structure of Artemisinin
Elemental analysis and nuclear magnetic resonance
spectroscopy indicated that artemisinin is a sesquiterpene
lactone with many oxygens present. The full structure
(Figure 3) was revealed by an investigation using X-ray
crystallography to show three fused alicyclic rings, one of
which is 7-membered and, most surprisingly, one ring is
spanned by a peroxide bridge. Peroxides are normally very
unstable, but in artemisinin the peroxide group is quite
stable, and artemisinin can be heated to 150 °C without
decomposition. Although the mode of action of artemisinin is uncertain, it is probably the peroxide group that
is responsible for its antimalarial activity. In the presence of a metal ion, such as the iron of hemoglobin, the
oxygen-oxygen bond breaks giving rise, after a series of
transformations, to carbon-centered radicals that destroy
the malarial parasite (Butler et al. 1998; Meshnick 2002).
All the three chemical features mentioned (fused alicyclic
rings, a 7-membered ring and the peroxide bridge) are
unusual in a plant natural product, and to find all three in
the same material is astonishing. When news of artemisinin reached the West, there was considerable skepticism,
particularly over the chemical structure, but the Chinese
work was fully confirmed by other researchers.
Artemisinin is not an ideal drug as its low water solubility
limits its bioavailability. Therefore, it has been chemically modified to give an even better drug. The most
successful modification is to convert it into the half ester
of succinic acid to give artesunate (Figure 4) (Rosenthal
2008). This is generally the form in which artemisinin is
HIMALAYA Volume 39, Number 1 | 223

Figure 3. Chemical structure of artemisinin.
(Butler, 2019)

used therapeutically, although there are other chemical
modifications in use. Artesunate is water-soluble and can
be used orally, rectally, intramuscularly, or intravenously.
As is the case with quinine, parts of the molecule may not
be necessary for its antimalarial action, and simpler molecules with a trioxolane structure have been synthesized.
One, arterolane, looked promising in in vitro testing but
performed less well in clinical trials and has not challenged
artesunate’s position (Posner et al. 1999). For the largescale production of artemisinin, A. annua is cultivated by
small farmers in Africa and China, the leaves harvested and
sent to factories where artemisinin is extracted and purified. High-yield plants have been developed by a process
of selective breeding at the Centre for Novel Agricultural
Products at the University of York. One of the difficulties
with this system for the production of a product where
the demand is about the same each year is that farmers
are not willing to grow A. annua when the prices of other
farm products are high. Production of the drug in a factory
through biosynthesis involving genetically engineered
yeast is under development. This has recently become
quite successful and may provide a more reliable source.
However, farm-produced artemisinin will probably remain
an important source of the drug.
The Nobel Prize
In 2015, half the Nobel Prize in Physiology or Medicine was
awarded for the discovery of the antimalarial properties of
artemisinin. The other half of the Prize went to William C.
Campbell and Satoshi Ōmura for work on parasitic worms.
The Nobel Prize has to be awarded to a person, and one of
the problems was that all the early papers on artemisinin
were ascribed to groups rather than people. Thus, studies
of its clinical potential, although published in the Chinese
Medical Journal, were credited to the ’Collaborative research
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group on qinghaosu’ (Collaborative Research Group
1979: 811-816), and its crystal structure was reported in
Scientia Sinica and credited to ‘Qinghaosu Research Group’
(Qinghaosu Research Group 1980). However, investigation
revealed Tu Youyou as the person largely responsible for
the herbal work, and she went to Stockholm to collect
the Prize.
Artemisinin Combination Therapy
Not long after artemisinin (which includes the original
drug and all its chemical modifications used therapeutically) was first used as a treatment for malaria, it became
clear that resistance to artemisinin could develop quite
readily. In some parts of Southeast Asia, it was sold
over the counter, and there was no attempt at ensuring
compliance. Now that artemisinin is the frontline drug in
the treatment of cerebral and vivax malaria, preventing
resistance is a matter of great importance. To lose the drug
because of resistance, as was the case with chloroquine,
would be a major tragedy as no new antimalarial drug is
waiting in the wings to take its place.
The World Health Organisation (WHO) strongly recommends that, in the treatment of uncomplicated cerebral
malaria, artemisinin should always be given in combination with another antimalarial drug, as Artemisinin
Combination Therapy (ACT) (Rehwagen 2006). An ACT is a
combination of fast-acting, highly potent artemisinin with
a slow-acting, less potent drug such as mefloquine, piperaquine, and even chloroquine. ACT is normally given over
three days. Artemisinin kills the vast majority of the parasites by one mechanism, and the partner drug eliminates
any remaining parasites over a much longer time period
by another mechanism. It is thought that the two drugs
protect one another from the development of resistance.
However, combination therapy is expensive. Many poorer

Figure 4. Chemical structure of artesunate.
(Butler, 2019)

countries have tried to use a monotherapy to control
malaria, but this is dangerous not only for that country
but also its neighbors, as the artemisinin-resistant parasite
does not recognize national boundaries. To avoid the use
of monotherapies, the WHO has urged manufacturers to
package the drugs in such a way that two components are
given together.
Much is known at a molecular level about the cause of
drug resistance, and its development can be predicted by
blood tests. In Western Cambodia, where resistance even
to an ACT has developed, frequent tests would allow the
ACT used in surrounding provinces to be changed before
resistance has taken hold (Noedl et al. 2008). The success of
combination therapy in the treatment of malaria suggests
that it may be the way forward in the treatment of other
diseased states, particularly those treated with antibiotics,
but it is bound to be more expensive.
The Future of Drug Discovery
The era of small drugs—that is, molecules of below 400
daltons—is coming to a close (Le Fanu 1999). Drugs like
penicillin, aspirin, and the sulphonamides have made
enormous improvements to human life, but most bioactive
substances (which includes therapeutic drugs) are much
larger molecules. Synthesizing large molecules with the
hope that they will display drug action when tested is
too demanding a program to undertake, as up to 1,000
compounds may be needed to find the one that is active
enough to submit for full clinical trials. However, natural
products (i.e., substances that can be extracted from living

sources such as plants, animals, and microorganisms) are
a ready source of such compounds. We therefore look to
living things, principally herbs, for possible therapeutic
drugs, as they do the task of synthesis effortlessly, having
been provided with enzymes to do the job.
The constituents of the herbal extract are identified and
tested for biological activity by a technique known as High
Throughput Screening. This approach to drug discovery
has proved successful in the past. For example, taxol or
paclitaxel was found in an extract from the Californian
yew tree during a massive screening of many thousands
of natural products found in US plants and trees. This
survey was financed by the US Government. Evidence of
anti-cancer activity with the extract led to a more detailed
study. From this, the first successful drug for the treatment of ovarian cancer emerged. The effort involved in
making this discovery was enormous, and government
finance was required. Initially, the cost of taxol was costly,
which does very little for the general health of humankind. Fortunately, some very clever chemistry involving
chemical modification of a more abundant natural product
reduced the cost substantially, and taxol is now generally
available (see also Tidwell and Nettles 2019).
We are in a promising era for this type of drug discovery,
as a number of sophisticated techniques for the separation
of the complex mixtures obtained during extraction, and
the chemical identification of the components are available. They mostly involve some form of chromatography
linked to mass spectrometry. Moreover, in recent years it
has been discovered that life can flourish under extreme
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conditions, such as in hot springs or at very high pressure at the bottom of the sea. Living things found in such
places must have unique physiologies, possibly involving
substances not found elsewhere and, possibly, new to
chemistry. These are exciting possibilities to develop new
drugs for conditions untouched by current therapies.
If herbal medicine is used to select the plants studied,
there is a sense in which some of the screening has been
done already by countless herbalists over hundreds
of years. The chances of success are higher but, disappointingly, rarely is a new drug born in this way. Herbal
medicine generally yields a weak drug or one no better
than that already available. The discovery of artemisinin
is a case when it did work, and worked spectacularly well.
The herbs of a country with an unusual or little studied
flora are of particular interest, especially if the medicinal
values of the herbs have been recorded. However, for
many herbalists, by extracting the active principle from
the herb we are missing the point of herbal medicine
(Butler and Keating 2011). They insist that it is the whole
plant, rather than its components, that give it medicinal
value. This proposition poses a considerable challenge
when it comes to be tested experimentally as herbal
extracts often vary in composition. It would be better if
the constituents were identified and the pure compounds
identified were paired, say, and the biological activity of
each pair tested. There might be up to fifty biologically
significant compounds in an herbal extract. Consequently,
there would be many pairs, and the work would be both
tedious and expensive but not impossible. If a pair showed
enhanced therapeutic activity, this would suggest that
there was some sort of synergy between the constituents
of the pair.
The success of ACT in both preventing resistance and
enhancing the power of the drug, as described previously, does suggest that mixtures are better than single
substances, and sometimes it is a case of ‘2+2 = 5.’ The
effect of the combination is greater than the sum of its
parts (see also Schwabl and van der Valk 2019). This is
known to be true also for the treatment of tuberculosis
and leprosy; malaria is in no way special. More experimental work is required if this approach to chemotherapy
is to be of general value. It is interesting to note that, in
cinchona bark, there are two antimalarial alkaloids, as
described previously. Possibly, they act synergistically to
give the bark a curative power, which is greater than the
small amount of quinine present in cinchona bark might
have suggested. There is evidence of synergistic effects
in the herbal remedies used for the treatment of malaria
(Rasoanaivo et al. 2011).
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Conclusion
The isolation of artemisinin from Artemisia annua during
the most testing of times, was an example of the triumph
of perseverance and good scientific skills. Many people
were involved in its success that it would have been fairer
had others shared the Nobel Prize with Tu Youyou, which
was not possible according to the rules. The story of the
birth of artemisinin, when told in outline, is a simple one:
a common herb, used for centuries by Chinese physicians
for the treatment of fever, is now being used worldwide for
the treatment of malaria, but that hides much of the good
science for which the Nobel Prize was awarded. First, there
was the problem of identifying malaria in the ben cao and
choosing the correct species of Artemisia for study. Second,
finding the correct procedure for extraction of the drug
was a challenge. Drug action is enhanced by extraction.
Since extraction concentrates the drug (and thus makes it
more powerful), it might be seen as a process that parallels, in modern chemotherapy, the potentiation gained
by drug-drug interaction in biomedicine (Jia et al. 2009).
Further potentiation, using the term in its more expansive
sense, was possible once the chemical structure (mainly
from nuclear magnetic resonance spectroscopic and X-ray
crystallographic studies) had been elucidated. This allowed
chemists to see how the molecule could be modified to
increase its bioactivity by making it more water-soluble. It
turned out that the most successful way of achieving that
was to convert artemisinin into the half ester of succinic
acid, to give artesunate. The final step in potentiation
was setting up the regimens for artemisinin combination
therapy. The drug is potentiated so that resistance will not
diminish its power. The attempt at further potentiation by
making simpler molecules that contain just the essential
part of the artemisinin molecule has been unsuccessful
so far. It is perhaps stretching the meaning of the term
potentiation somewhat, but promising work on the
industrial synthesis of artemisinin, which should reduce
its cost, could be considered part of that process. Designing
new and costly drugs for diseases that are endemic in poor
parts of the world is valueless. Instead, basing a drug on an
existing herbal remedy that has been potentiated is much
more likely to come up with an affordable drug. Many
thousands throughout the world who owe their lives to the
development of ACT should be grateful to Tu Youyou and
Project 523.
There is one remaining matter for consideration. For the
last century or so, one of the aims of pharmacology has
been to extract from herbs the active principle and, as new
herbs are examined, this is still important. However, it is
just as important to examine other substances present in

the herb in order to understand better how potentiation
may be achieved by drug-drug interactions and synergy.
The presence of substances in the herb, other than the lead
compound, may help in avoiding the build up of resistance.
Nature may have many more secrets, yet to be revealed.
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